Específicos Stendhal S.A. de C.V.

repaid

The aim of this IIC operation is to provide Stendhal with a loan to partially finance the expansion of its portfolio of products sold in Mexico and other Latin American countries.Stendhal, Maypo, and StInt are subsidiaries of Grupo Arfeldt S.A. de C.V., a holding company. The group’s companies are engaged in the production, distribution, logistics, and marketing of pharmaceuticals in Latin America. Grupo Arfeldt comprises 11 subsidiary companies with direct business operations in eight countries, distribution centers in Mexico City and Panama City, and a manufacturing center in the State of Mexico.Founded in 1974, Stendhal is a Mexican pharmaceutical laboratory that produces, imports, and markets specialized medications. In 2010, it received a transparency award from the Mexican pharmaceutical industry’s Council of Ethics and Transparency (CETIFARMA) in recognition of its good health promotion and transparent business practices. In January 2012, it was recognized by Mexico’s Confederation of Industrial Chamber (CONCAMIN) with an award for exemplifying pharmaceutical industry ethics and values. This award is bestowed on companies that conduct their business in accordance with values-based business models and develop in-house and community corporate social responsibility programs.Established in 1993, Maypo is a distributor of specialized medications. It sells pharmaceutical products to the public sector in Mexico, including those produced and imported by Stendhal.StInt is a holding company that consolidates the operations of Grupo Arfeldt in a number of countries in Latin America, including Colombia, Costa Rica, El Salvador, Guatemala, Panama, and Venezuela.